Does consuming aspartame increase the risk of cancer?
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Aspartame Consumption and Cancer Risk: A Comprehensive Review
Introduction to Aspartame and Its Usage
Aspartame is a widely used artificial sweetener found in over 5,000 food products globally, including low-calorie beverages, which are particularly popular among children and pregnant women. Given its extensive use, understanding the potential health risks associated with aspartame, particularly its link to cancer, is crucial.
Animal Studies on Aspartame and Cancer
Findings from the Ramazzini Institute
The Ramazzini Institute (RI) conducted studies in 2006 and 2007, which indicated that aspartame causes dose-related increases in malignant tumors in multiple organs in rats and mice. These studies found increased cancer risk even at low exposure levels, with prenatal exposures causing higher malignancies in rodent offspring. Despite initial controversy over the accuracy of these findings, further immunohistochemical and morphological reassessments confirmed the original diagnoses of malignancy in 92.3% of cases, validating the RI's conclusions that aspartame is a chemical carcinogen in rodents.
Contradictory Animal Study Results
However, other animal studies have not consistently supported these findings. Several studies have found no significant increase in cancer risk associated with aspartame consumption . For instance, the U.S. Food and Drug Administration (FDA) reviewed multiple studies and concluded that aspartame did not contribute to brain tumor formation in rats.
Human Epidemiological Studies
NIH-AARP Diet and Health Study
A large-scale study involving 285,079 men and 188,905 women aged 50 to 71 years from the NIH-AARP Diet and Health Study found no significant association between aspartame intake and the risk of hematopoietic cancers or gliomas. The study concluded that higher levels of aspartame intake were not linked to an increased risk of these cancers .
Spanish Multicase-Control Study (MCC-Spain)
The MCC-Spain study, which included 1881 colorectal, 1510 breast, 972 prostate, and 351 stomach cancer cases, along with 3629 population controls, also found no significant association between aspartame consumption and cancer risk.
NutriNet-Santé Cohort Study
In contrast, the NutriNet-Santé cohort study, which followed 102,865 adults over a median of 7.8 years, found that higher consumers of artificial sweeteners, including aspartame, had a higher risk of overall cancer. Specifically, aspartame was associated with increased risks of breast cancer and obesity-related cancers.
Childhood Brain Tumor Risk
A case-control study investigating the link between aspartame consumption and childhood brain tumors found no significant association. The study included data from children diagnosed with primary brain tumors and control subjects, and it observed no elevated brain tumor risk from maternal or child consumption of aspartame.
Conclusion
The evidence on aspartame and cancer risk is mixed. While some animal studies suggest a potential carcinogenic effect, particularly at high doses, most human epidemiological studies do not support a significant association between aspartame consumption and cancer risk. However, some recent cohort studies indicate a possible increased risk for certain cancers, warranting further investigation. Given the widespread use of aspartame, continued research and re-evaluation by health agencies are essential to ensure public safety.
Sources and full results
Most relevant research papers on this topic